Hypolipidemic agents and gallstones.
D002769:Cholelithiasis / Q000139:chemically induced*; D002792:Cholestyramine Resin / Q000009:adverse effects*; D002994:Clofibrate / Q000009:adverse effects*; D003084:Colestipol / Q000009:adverse effects*; D006801:Humans; D011073:Polyamines / Q000009:adverse effects*
D011073:Polyamines; D002792:Cholestyramine Resin; D002994:Clofibrate; D003084:Colestipol